Logistic discriminant analysis of lipids and apolipoproteins in a population of coronary bypass patients and the significance of apolipoproteins C-III and E

      This paper is only available as a PDF. To read, Please Download here.


      The lipid and apolipoprotein states of 74 men (mean age 49.96 ± 5.9 years) were studied 24 h before coronary bypass surgery and their results were compared with those of a control group of 78 men (mean age 48.88 ± 5.41 years). Apolipoproteins C-III (apo C-III) and E (apo E) were determined in particles with (LpB) and without (nonLpB) apo B separated using a concanavalin A reagent. Apo C-111 was significantly increased in LpB particles (P < 0.001), and apo E in LpB (P < 0.001) and nonLpB (P < 0.001) particles. The significant variables selected in logistic discriminant stepwise analysis were total cholesterol/HDLcholesterol, apo E-nonLpB and apo C-III-LpB. This last parameter, which is more discriminant than triglycerides, provides a more specific indication of dyslipoproteinemia in coronary bypass patients; in association with the other two variables, it significantly improved the percentage of correctly classified individuals.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Mainard F.
        • Krempf M.
        • Bigot E.
        • Petit T.
        • Madec Y.
        Lipidic disturbances and other risk factors in a population of atheromatous subjects before bypass surgery.
        in: Lenzi S. Descovich G.C. 3rd edn. Atherosclerosis and Cardiovascular diseases. vol 3. Editrice Compositori, Bologna1987
        • Neitzel G.F.
        • Barboriak J.J.
        • Pintar K.
        • Qureshi I.
        Atherosclerosis in aortocoronary bypass grafts. Morphologic study and risk factor analysis 6 to 12 years after surgery.
        Arteriosclerosis. 1986; 6: 594
        • Fox M.H.
        • Gruchow H.W.
        • Barboriak J.J.
        • Anderson A.J.
        • Hoffman R.G.
        • Flemma R.J.
        • King J.F.
        Risk factors among patients undergoing repeat aorta-coronary bypass procedures.
        J. Thorac. Cardiovasc. Surg. 1987; 93: 56
        • Trinder P.
        Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor.
        Ann. Clin. Biochem. 1969; 6: 24
        • Kostner G.M.
        • Avogaro P.
        • Bittolobon G.
        • Cazzolatto G.
        • Quinci G.B.
        Determination of high density lipoproteins: screening methods compared.
        Clin. Chem. 1979; 25: 939
        • Friedewald W.T.
        • Levy R.I.
        • Fredrickson S.D.
        Estimation of the concentration of LDL cholesterol in plasma without of the preparative ultracentrifuge.
        Clin. Chem. 1972; 18: 499
        • Munscher G.
        • Metzmann E.
        • Ziegenbein W.
        Standardization procedure of immunochemical apolipoprotein quantitation.
        Ric. Clin. Lab. 1982; 12: 143
        • McConathy W.J.
        • Alaupovic P.
        Studies on the interaction of concanavalin A with major density classes of human plasma lipoproteins. Evidence of the specific binding of lipoprotein B in its associated and free forms.
        FEBS Lett. 1974; 41: 174
        • Fruchart J.C.
        • Fievet C.
        • Puchois P.
        Apolipoproteins Metabolites III: lipids, aminoacids and related compounds.
        in: Bergmeyer H.U. Methods of Enzymatic Analysis. VCH publications, New York1985: 126
        • Lebart L.
        • Morineau A.
        • Warwick K.M.
        Multivariate descriptive statistical analysis.
        J. Wiley and Sons, New York1984
        • Cox D.R.
        The analysis of binary data.
        Chapman and Hall, London1970
        • Berglund G.
        • Andersson O.
        Beta-blockers or diuretics in hypertension. A six year follow up of blood pressure and metabolic side-effects.
        Lancet. 1981; 4: 744
        • Kristensen B.
        Effect of long term treatment with betablocking drugs on plasma lipids and lipoproteins.
        Br. Med. J. 1981; 2: 191
        • Glynn R.J.
        • Rosner B.
        • Silbert J.E.
        Changes in cholesterol and triglycerides as predictors of ischemic heart disease in men.
        Circulation. 1982; 66: 724
        • Barth J.D.
        • Jansen H.
        • Kromhout D.
        • Reiber J.H.C.
        • Birkenhager J.C.
        • Arntzenius A.C.
        Progression and regression of human coronary atherosclerosis. The role of lipoproteins, lipoprotein lipase and thyroid hormones in coronary lesion growth.
        Atherosclerosis. 1987; 68: 51
        • Castelli W.P.
        Epidemiology of coronary heart disease. The Framingham Study.
        Am. J. Med. 1984; 76: 4
        • Yano T.
        • Nakamura N.
        • Uzawa M.
        • Kobori S.
        • Maruyama N.
        • Takeda H.
        • et al.
        Multiple regression analysis of sixteen risk factors including apolipoproteins in angiographically documented artery disease.
        Jpn. Circ. J. 1987; 51: 383
        • Reardon M.F.
        • Nestel P.J.
        • Graig I.H.
        • Harper R.N.
        Lipoprotein predictors of the severity of coronary artery disease in men and women.
        Circulation. 1985; 71: 881
        • Havel R.J.
        • Shore V.G.
        • Shore B.
        • Bier D.M.
        Role of specific glycopeptides of human serum lipoproteins in the activation of lipoprotein lipase.
        Circ. Res. 1970; 27: 595
        • Ginsberg H.N.
        • Ngoc-Anh L.E.
        • Golberg I.J.
        • Gibson J.C.
        • Rubinstein A.
        • Wang-Iverson P.
        • Norum R.
        • Brown W.V.
        Apolipoprotein B metabolism in subjects with deficiency of apolipoprotein C11, and Al: evidence that apolipoprotein C111 inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
        J. Clin. Invest. 1986; 78: 1287
        • Windler E.
        • Havel R.J.
        Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver.
        J. Lip. Res. 1985; 26: 556
        • Shelburne F.
        • Hanks J.
        • Meyers W.
        • Quarfordt S.
        Effects of apoproteins on hepatic uptake of triglyceride emulsion in the rat.
        J. Clin. Invest. 1980; 65: 652
        • Utermann G.
        Apolipoprotein E polymorphism in health and disease.
        Am. Heart J. 1987; 113: 433